Celyad Oncology SA CLYYF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 138.20K | 139.50K | 2.01M | 2.00M | 927.80K |
| Total Receivables | 831.70K | 839.40K | 931.10K | 930.40K | 892.50K |
| Inventory | 28.60K | 28.80K | -- | -- | 299.50K |
| Prepaid Expenses | -4.60K | -4.60K | 305.30K | 305.10K | 711.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.10K | 1.20K | 864.20K | 863.50K | 54.00K |
| Total Current Assets | 995.10K | 1.00M | 4.11M | 4.10M | 2.89M |
|
|
|||||
| Total Current Assets | 995.10K | 1.00M | 4.11M | 4.10M | 2.89M |
| Net Property, Plant & Equipment | -- | -- | 0.00 | 0.00 | 1.57M |
| Long-term Investments | -- | -- | 0.00 | 0.00 | -- |
| Goodwill | -- | -- | 0.00 | 0.00 | -- |
| Total Other Intangibles | 14.90K | 15.00K | 18.80K | 18.80K | 22.30K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.65M | 1.66M | 921.70K | 921.00K | 2.21M |
| Total Assets | 2.66M | 2.68M | 5.05M | 5.04M | 6.69M |
|
|
|||||
| Total Accounts Payable | 250.20K | 252.50K | 600.00K | 599.60K | 1.08M |
| Total Accrued Expenses | 164.50K | 166.00K | 440.30K | 440.00K | 461.50K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 90.40K |
| Total Finance Division Other Current Liabilities | 647.80K | 653.80K | 1.09M | 1.09M | 2.73M |
| Total Other Current Liabilities | 647.80K | 653.80K | 1.09M | 1.09M | 2.73M |
| Total Current Liabilities | 1.06M | 1.07M | 2.13M | 2.13M | 4.37M |
|
|
|||||
| Total Current Liabilities | 1.06M | 1.07M | 2.13M | 2.13M | 4.37M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | 885.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 158.80K | 160.30K | 51.70K | 51.60K | 5.08M |
| Total Liabilities | 1.22M | 1.23M | 2.19M | 2.18M | 10.33M |
|
|
|||||
| Common Stock & APIC | 10.49M | 10.59M | 10.82M | 10.81M | 9.65M |
| Retained Earnings | -416.52M | -420.36M | -426.64M | -426.34M | -432.03M |
| Treasury Stock & Other | 407.46M | 411.22M | 418.68M | 418.38M | 418.74M |
| Total Common Equity | 1.43M | 1.45M | 2.86M | 2.86M | -3.64M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.43M | 1.45M | 2.86M | 2.86M | -3.64M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.43M | 1.45M | 2.86M | 2.86M | -3.64M |
|
|
|||||